Search Results - "Olsovsky, Jindrich"

Genetic variability in enzymes of metabolic pathways conferring protection against non-enzymatic glycation versus diabetes-related morbidity and mortality by Tanhäuserová, Veronika, Kuricová, Katarína, Pácal, Lukáš, Bartáková, Vendula, Rehořová, Jitka, Svojanovský, Jan, Olšovský, Jindřich, Bělobrádková, Jana, Kaňková, Kateřina

“…We hypothesized that genetic variability in genes encoding enzymes metabolizing glycolytic intermediates produced in excess under hyperglycemic conditions…”
Get more information

Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients by Kaňková, Kateřina, Bělobrádková, Jana, Svojanovský, Jan, Řehořová, Jitka, Malúšková, Denisa, Dvořáková, Veronika, Kianičková, Katarína, Klimešová, Linda, Bartáková, Vendula, Olšovský, Jindřich

“…Elevated resting heart rate (RHR) has been associated with increased risk of mortality and cardiovascular events. Limited data are available so far in type 2…”
Get full text

ADMA, SDMA and L-arginine/ADMA Ratio but not DDAH Genetic Polymorphisms are Reliable Predictors of Diabetic Nephropathy Progression as Identified by Competing Risk Analysis by Tanhäuserová, Veronika, Tomandl, Josef, Pácal, Lukáš, Klepárník, Martin, Malúšková, Denisa, Bartáková, Vendula, Kuricová, Katarína, Řehořová, Jitka, Štěpánková, Soňa, Svojanovský, Jan, Olšovský, Jindřich, Bělobrádková, Jana, Krusová, Darja, Jurajda, Michal, Mužík, Jan, Pavlík, Tomáš, Kaňková, Kateřina

“…Background/Aims: Complex interplay of genetic and (patho)physiological factors influence availability of nitric oxide during the development and progression of…”
Get full text

Role of thiamine status and genetic variability in transketolase and other pentose phosphate cycle enzymes in the progression of diabetic nephropathy by PACAL, Lukáš, TOMANDL, Josef, MUZIK, Jan, KANKOVA, Kateřina, SVOJANOVSKY, Jan, KRUSOVA, Darja, STEPANKOVA, Soňa, REHOROVA, Jitka, OLSOVSKY, Jindřich, BELOBRADKOVA, Jana, TANHÄUSEROVA, Veronika, TOMANDLOVA, Marie

“…Pentose phosphate pathway (PPP) represents a potentially 'protective' mechanism in hyperglycaemia due to shunting of glycolytic intermediates into PPP…”
Get full text

Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study by Raputova, Jana, Srotova, Iva, Vlckova, Eva, Sommer, Claudia, Üçeyler, Nurcan, Birklein, Frank, Rittner, Heike L., Rebhorn, Cora, Adamova, Blanka, Kovalova, Ivana, Kralickova Nekvapilova, Eva, Forer, Lucas, Belobradkova, Jana, Olsovsky, Jindrich, Weber, Pavel, Dusek, Ladislav, Jarkovsky, Jiri, Bednarik, Josef

“…Different sensory profiles in diabetic distal symmetrical sensory-motor polyneuropathy (DSPN) may be associated with pain and the responsiveness to analgesia…”
Get full text

Risk factors for depression and anxiety in painful and painless diabetic polyneuropathy: A multicentre observational cross‐sectional study by Kec, David, Rajdova, Aneta, Raputova, Jana, Adamova, Blanka, Srotova, Iva, Nekvapilova, Eva Kralickova, Michalcakova, Radka Neuzilova, Horakova, Magda, Belobradkova, Jana, Olsovsky, Jindrich, Weber, Pavel, Hajas, Gabriel, Kaiserova, Michaela, Mazanec, Radim, Potockova, Veronika, Ehler, Edvard, Forgac, Martin, Birklein, Frank, Üçeyler, Nurcan, Sommer, Claudia, Bednarik, Josef, Vlckova, Eva

“…Background Despite the high prevalence of depression and anxiety in chronic pain conditions, current knowledge concerning emotional distress among painful…”
Get full text

Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus by Bartakova, Vendula, Kuricova, Katarina, Pacal, Lukas, Nova, Zuzana, Dvorakova, Veronika, Svrckova, Martina, Maluskova, Denisa, Svobodova, Ivana, ehorova, Jitka, Svojanovsky, Jan, Olsovsky, Jindrich, Blobradkova, Jana, Kakova, Katerina

“…Abstract Aims The aims of the study were (i) to ascertain prognostic value of serum uric acid (SUA) for diabetic kidney disease (DKD) progression and major…”
Get full text

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients : The Di.N.A.S. randomized trial by GAMBARO, Giovanni, KINALSKA, Ida, SKRHA, Jan, TATON, Jan, GRZESZCZAK, Wladyslaw, CREPALDI, Gaetano, OKSA, Adrian, PONT'UCH, Peter, HERTLOVA, Miluse, OLSOVSKY, Jindrich, MANITIUS, Jacek, FEDELE, Domenico, CZEKALSKI, Stanislaw, PERUSICOVA, Jindriska

“…Diabetic nephropathy may be effectively prevented and treated by controlling glycemia and administering angiotensin-converting enzyme (ACE) inhibitors…”
Get full text

Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene by Ka ková, Kate Ina, Kalousová, Marta, Hertlová, Miluše, Krusová, Darja, Olšovský, Jind ich, Zima, Tomáš

“…Abstract Diabetes mellitus, especially when complicated with decline of renal function due to diabetic nephropathy (DN), is associated with accumulation of…”
Get full text

Possibilities of influencing cardiovascular risk in type 2 diabetes mellitus by antidiabetic treatment Lowering of cardiovascular risk in treatment with liraglutide - Results of the LEADER by Olšovský, Jindřich

“…The article summarizes current knowledge about the possibilities for influencing the cardiovascular risk in treatment of type 2 diabetes, especially focusing…”
Get more information

Treatment of GLP1 receptor agonists and body mass control by Žák, Petr, Olšovský, Jindřich

“…The prevalence of obesity continues to be increasing in all age groups in most countries of the European Union (EU). Many obese people have a history of…”
Get more information